AC Immune SA (ACIU) Financials
ACIU Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 217.4 million | 26.4 million |
2023-09-30 | 156.2 million | 18.9 million |
2023-06-30 | 173.8 million | 18.8 million |
2023-03-31 | 185.1 million | 17.7 million |
ACIU Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -19.5 million | 947799 |
2023-09-30 | -14.8 million | 946968 |
2023-06-30 | -15.9 million | 1.4 million |
2023-03-31 | -18.6 million | 1.6 million |
ACIU Net Income
No data available :(
ACIU Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 122.5 million | - | 4.2 million |
2023-09-30 | 87.3 million | - | 2.6 million |
2023-06-30 | 103.5 million | - | 2.8 million |
2023-03-31 | 115.4 million | - | 2.9 million |
ACIU Shares Outstanding
ACIU Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 197408 | 17.4 million | 803905 | - |
2023-09-30 | 305826 | 13.6 million | 3.8 million | - |
2023-06-30 | 172414 | 15.2 million | 4.1 million | - |
2023-03-31 | 218815 | 15.2 million | 4.5 million | - |
ACIU Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 17.6 million | 17.4 million |
2023-09-30 | - | 13.6 million |
2023-06-30 | - | 15.2 million |
2023-03-31 | - | 15.2 million |
ACIU
Price: $2.39
52 week price:
Earnings Per Share: -0.71 USD
P/E Ratio: -3.24
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 182100
Ebitda: -8.8 millionMarket Capitalization: 232.4 million